Introducing GPT-Rosalind for life sciences research

The AMW Read

Updates the player map for Segment 06 by introducing a major frontier lab (OpenAI) into the vertical life sciences research space with a specialized model.

NoveltySignificance

Healthcare & Bio · Player Map

OpenAI

Foundation Models / LLMs

View Company Profile

Introducing GPT-Rosalind for life sciences research

OpenAI has introduced GPT-Rosalind, a new AI model designed to accelerate research in drug discovery, genomics, and protein analysis.

Original source: https://openai.com/index/introducing-gpt-rosalind/

#AI#life sciences#drug discovery#OpenAI

Explore OpenAI Read Original

How This Connects

Based on Healthcare & Bio · Player Map

21h agoWarp Sciences raises $215 million for robotic drug-discovery labsWarp Sciences
2d agoOpenAI acquires Orchestra Bio to expand Rosalind's biotech workflowsOpenAI
6d agoInsitro secures AstraZeneca collaboration for AI discovery in liver and heart diseaseInsitro
1mo agoLevel Five, a game developer, has issued a public apology after facing criticism for what it called...Level Five
6mo agoIntroducing GPT-Rosalind for life sciences research · THIS ARTICLE

Introducing GPT-Rosalind for life sciences research

The AMW Read

Original source: https://openai.com/index/introducing-gpt-rosalind/

How This Connects

Related News

OpenAI opens Decisions API to all customers for low-latency classification

OpenAI brings frontier models and Codex workflows to Google Cloud's Model Garden

OpenAI plans Google Cloud model distribution in deal with an AI rival

OpenAI reportedly seeks $30 billion before Anthropic's expected IPO

More news from OpenAI

Discover AI Startups